Right Treatment, First Time, Every Time

Revolutionizing treatment with AI-powered genetic analysis for personalized care.

Photo of a provider's hands writing a prescription for medication. Multiple medication choices are also visible in the image.
Precision

Transforming Treatment with Genetic Insights

GeneLeap is building a platform that leverages a patient’s genetic profile to deliver tailored treatment recommendations with the goal of shifting from trial-and-error prescribing to swift, effective care, with an initial focus on Depression.

30%

Thirty percent of depression patients have a full response to the first antidepressant they are prescribed, with less than 70% achieving remission after four lines of treatment. 1

37%

Thirty-seven percent of depression patients experience an adverse event related to the prescription of the most common first-line therapies. 2

denys-nevozhai-z0nVqfrOqWA-unsplash.
Graphic image showing an AI-predicted structure of an antidepressant-bound sodium dependent serotonin transporter (SERT) compared to an experimental one. Highlighted side chains are the binding pocket residues of the two protein structures.
An icon of a microscope

Scientific

Potential to eliminate the typical trial-and-error process of prescribing drugs by using an individual’s genetic data to evaluate and rank treatments for optimal effectiveness.

Icon of the two brain hemispheres with a plus-sign overlaid

Comprehensive

Using generative AI, GeneLeap can model any genetic variants in any combination that impact the efficacy of antidepressants and other drugs.

Icon of a DNA helix

Scalable

GeneLeap’s proprietary drug-receptor analysis can be applied across clinical conditions from Depression to other Neurological conditions, Autoimmune and Metabolic diseases, and more.

Icon of a medical shield

Optimized

GeneLeap’s goal is to reduce patient suffering and costs, and increase compliance, by delivering clear, actionable treatment recommendations at the outset of the treatment process.

How It Works

Unlocking a New Era for Precision Medicine

At GeneLeap, we are developing generative AI-based methods to model interactions between drugs and their targets encoded in a patient’s genome to predict which drugs will work best for that individual. Our innovative solution equips providers with a novel, precise way to prescribe antidepressants, giving patients a path to effective treatments sooner.

Photo of DNA sequences displayed on a computer screen

Comprehensive Analysis of Drug Activity

We examine an individual’s genome to model the exact proteins involved in each drug’s mechanism of action in order to rank treatment options.

Understanding All of a Drug's Actions

We plan to validate our AI-based methods, demonstrating that they provide a more comprehensive analysis going far beyond traditional approaches.

Photo of a medical provider reading a report on a computer screen

Actionable
Insights

GeneLeap’s ordering is simple, and providers receive clear reporting that makes it easy to address patients’ treatment needs quickly and effectively.

Impact

Transforming Lives Through Genetic Insights

GeneLeap is revolutionizing precision medicine by making individualized, genetics-based treatment optimization the new standard. Our innovative approach ensures that patients receive the most effective therapies tailored to their unique genetic profiles.

🔹 Empowering patients and providers with personalized treatment solutions.

🔹 Enhancing healthcare through data-driven decision making.

🔹 Setting a new standard in precision medicine.

Photo of a young person taking a walk in nature. The path leads to a sunny area.

About Us

At newly launched GeneLeap, we are passionate about improving lives using innovations built from the latest advances in biomedical and information technologies. We focus first on patients, and their providers, to identify challenges in medicine that new science and technologies can tackle. We value the highest scientific principles, integrity, transparency and compassion–for patients, their physicians, our team and collaborators.

We are building a highly motivated team of diverse experts that share our vision and have experience introducing pioneering products into the health sciences. Please contact us to join the effort!

🌟 Your Depression Treatment Story Can Change Lives - Share It Today 🌟 We're seeking stories about the challenges of finding effective depression medication. Whether you've struggled with multiple medications, experienced side effects, or found success after a long journey, your story is valuable.

➡️ Share Your Story Anonymously - Help Us Revolutionize Depression Treatment

Together, we can shorten the path to effective treatment for millions.

Background coloration in GeneLeap's brand blue

Read our company launch announcement from Leap AI!        Learn more

Team

Leadership

Photo of Tod Klingler, Ph.D. GeneLeap's CEO
Tod Klingler, Ph.D.
Co-founder & CEO
Photo of Mikko Koskinen, Ph.D. GeneLeap's CTO
Mikko Koskinen, Ph.D.
Co-founder & CTO

GeneLeap is the first venture to be spun out of Leap AI, an innovation studio focused on harnessing the power of artificial intelligence to solve complex healthcare challenges. 

Corporate logo for Leap AI venture studio
Let's Connect

Interested in Working with GeneLeap?

We'd love to hear from you!

Thank you! Your
Oops! Something went wrong while submitting the form.